Abstract
The abnormal phosphatase and tensin homolog expression and activated phosphoinositide-3 kinase/Protein kinase B (AKT)/mammalian target of rapamycin signaling pathway are involved in the progression of esophageal squamous cell carcinoma. By assessing the expression pattern of key components in the phosphoinositide-3 kinase/AKT/mammalian target of rapamycin signaling pathway by immunohistochemistry in tumor and nontumor esophageal mucosa from patients with esophageal squamous cell carcinomas, we aimed to carefully explore the relationship between the various protein expressions and clinicopathological factors, as well as patient outcome. A total of 145 tumor and 145 nontumor samples from patients with esophageal squamous cell carcinoma, collected from HuaShan Hospital (Shanghai, China) were evaluated. Clinical characteristics, the targeted protein expressions (including phosphatase and tensin homolog, phosphoinositide-3 kinase, AKT, p-AKT, mammalian target of rapamycin, p-mTOR, p70S6 kinase 1, p-P70S6K1, elongation initiation factor 4E binding protein-1, and p-4E-BP1, and survival rate were analyzed. Among them, phosphoinositide-3 kinase, AKT, p-AKT, mammalian target of rapamycin, p-mTOR, elongation initiation factor 4E binding p...Continue Reading
References
Apr 5, 2002·Cancer·Mitsuo TachibanaNaofumi Nagasue
Jul 3, 2002·Nature Reviews. Cancer·Igor Vivanco, Charles L Sawyers
May 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Farin KamangarWilliam F Anderson
Nov 18, 2008·Cancer Treatment Reviews·Alex S StrimpakosKostas N Syrigos
Jan 24, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michelle A T HildebrandtXifeng Wu
Apr 3, 2009·Nature Reviews. Molecular Cell Biology·Xiaoju Max Ma, John Blenis
Feb 16, 2012·British Journal of Cancer·K HirashimaH Baba
Jan 8, 2013·Wiener klinische Wochenschrift·Ning WuGang Chen
Apr 30, 2013·Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists·Dariusz WaniczekJerzy Arendt
Mar 13, 2014·British Journal of Cancer·K MalinowskyK-F Becker
Apr 2, 2014·Nature Genetics·De-Chen LinH Phillip Koeffler
Apr 30, 2014·PloS One·Alberto OcanaEitan Amir
May 13, 2014·Journal of Immunology Research·Guiqin HouZhaoming Lu
Oct 11, 2014·Oncology·Xianglan ZhangHyo Song Kim
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
Feb 6, 2015·Scientific Reports·Jinhong ZhuQingyi Wei
Sep 12, 2015·BioMed Research International·Jianjun LuYiyan Lei
Sep 15, 2015·OncoTargets and Therapy·Jieer YingHongming Pan
Jul 1, 2014·Thoracic Cancer·Wanqing ChenQinghua Zhou
May 5, 2016·Stem Cells·Hai-Feng ZhangRaymond Lai
Sep 12, 2016·Trends in Immunology·Nyamdelger SukhbaatarThomas Weichhart
Apr 7, 2017·Genetic Testing and Molecular Biomarkers·Jing-Wei LinBo Liu
Apr 19, 2017·Oncotarget·Bin LiAnnie L M Cheung
Oct 28, 2017·Nutrients·Mee-Sup Yoon
Jan 13, 2018·Cancers·Mathieu PaquetteArnim Pause
Citations
Sep 23, 2018·Journal of Cellular Biochemistry·Weiyang CaiChangyuan Hu
Jun 1, 2018·Diagnostic Pathology·Bao-Hua YuWen-Tao Yang
Aug 3, 2019·Cells·Jean Christopher ChamcheuShile Huang
Dec 11, 2019·British Journal of Cancer·Vittoria RaimondiVincenzo Ciminale
Oct 5, 2019·Cancer Cell International·Tian-Liang ZhengSong Zhao
May 30, 2019·Frontiers in Oncology·Shuo ZhangZengwu Shao
Apr 3, 2019·Journal of Cellular Biochemistry·Jin ZhangLiangzhang Sun
Jan 16, 2021·General Thoracic and Cardiovascular Surgery·Seiya InoueAkira Tangoku
Dec 29, 2020·Frontiers in Oncology·Zhen YaoYulong Liu
Feb 13, 2021·International Journal of Molecular Sciences·Nadezhda V Popova, Manfred Jücker
Nov 17, 2020·Frontiers in Oncology·Junyi ChenLongmin Fang
May 18, 2021·Frontiers in Medicine·Laura MercurioStefania Madonna
Aug 17, 2021·Medicine·Huiying WanHaiping Jia
Aug 19, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Guiqin HouZhaoming Lu